BCYC
Price
$6.47
Change
-$0.15 (-2.27%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
459.91M
47 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$18.86
Change
-$0.18 (-0.95%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.93B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs NRIX

Header iconBCYC vs NRIX Comparison
Open Charts BCYC vs NRIXBanner chart's image
Bicycle Therapeutics
Price$6.47
Change-$0.15 (-2.27%)
Volume$2.4K
Capitalization459.91M
Nurix Therapeutics
Price$18.86
Change-$0.18 (-0.95%)
Volume$15.53K
Capitalization1.93B
BCYC vs NRIX Comparison Chart in %
BCYC
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCYC vs. NRIX commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (BCYC: $6.62 vs. NRIX: $19.04)
Brand notoriety: BCYC and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 72% vs. NRIX: 59%
Market capitalization -- BCYC: $459.91M vs. NRIX: $1.93B
BCYC [@Biotechnology] is valued at $459.91M. NRIX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 2 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 2 bullish, 5 bearish.
  • NRIX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -3.64% price change this week, while NRIX (@Biotechnology) price change was +2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 03, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.93B) has a higher market cap than BCYC($460M). NRIX YTD gains are higher at: 0.369 vs. BCYC (-6.497). BCYC (-245.86M) and NRIX (-248.7M) have comparable annual earnings (EBITDA) . BCYC has more cash in the bank: 648M vs. NRIX (429M). BCYC has less debt than NRIX: BCYC (5.74M) vs NRIX (56.5M). NRIX has higher revenues than BCYC: NRIX (83.7M) vs BCYC (28.3M).
BCYCNRIXBCYC / NRIX
Capitalization460M1.93B24%
EBITDA-245.86M-248.7M99%
Gain YTD-6.4970.369-1,761%
P/E RatioN/AN/A-
Revenue28.3M83.7M34%
Total Cash648M429M151%
Total Debt5.74M56.5M10%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCNRIX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WFSAX27.70-0.04
-0.14%
Allspring Small Company Growth A
LRAGX18.04-0.03
-0.17%
Lord Abbett International Growth R3
AFCNX19.57-0.06
-0.31%
American Century Focused Intl Gr Inv
AGRCX128.75-1.73
-1.33%
AB Growth C
PRGTX27.09-0.37
-1.35%
T. Rowe Price Global Technology

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.00%
NRIX - BCYC
52%
Loosely correlated
+0.58%
RGNX - BCYC
50%
Loosely correlated
-0.66%
XNCR - BCYC
50%
Loosely correlated
+3.66%
NGNE - BCYC
50%
Loosely correlated
+10.91%
SYRE - BCYC
49%
Loosely correlated
+5.17%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.58%
KYMR - NRIX
65%
Loosely correlated
+1.46%
KURA - NRIX
55%
Loosely correlated
+1.63%
XNCR - NRIX
55%
Loosely correlated
+3.66%
OCUL - NRIX
54%
Loosely correlated
+6.14%
TYRA - NRIX
53%
Loosely correlated
+1.35%
More